Phathom Pharmaceuticals
Price & Volume
Stats
See moreOpen | $6.02 |
Previous Close | $5.74 |
Day Range | $5.68-$6.13 |
52W Range | $5.01-$18.31 |
Market Cap | $480.8M |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $274.8M |
Revenue Growth (YoY) | 71.1% |
Gross Profit (12 Mos) | $221.7M |
Diluted EPS | -$1.01 |
News
See moreYahoo Finance • 12 hours ago
Phathom Pharmaceuticals to Participate in November Investor Conferences
Yahoo Finance • 3 months ago
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Phathom Pharmaceuticals, Inc. (PHAT)
Yahoo Finance • 3 months ago
Phathom forecasts $310M-$325M 2026 revenue while planning Phase 3 as-needed GERD trial in Q4
Yahoo Finance • 4 months ago
Phathom Pharma Completes Enrollment In Phase 2 PHalcon-EoE-201 For Eosinophilic Esophagitis
About
CEO | Mr. Steven L. Basta M.B.A. |
Address | 100 Campus Drive, Florham Park, NJ, United States, 07932 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 371 |